Hans-ulrich U. Ulmer

Salem, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes.

Journal: Nature genetics

Published: December 13, 2018

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.

Journal: American journal of human genetics

Published: August 09, 2018

Genome-wide association study of germline variants and breast cancer-specific mortality.

Genome-wide association study of germline variants and breast cancer-specific mortality.

Journal: British journal of cancer

Published: August 06, 2018

Body mass index and breast cancer survival: a Mendelian randomization analysis.

Body mass index and breast cancer survival: a Mendelian randomization analysis.

Journal: International journal of epidemiology

Published: June 29, 2017

Association analysis identifies 65 new breast cancer risk loci.

Association analysis identifies 65 new breast cancer risk loci.

Journal: Nature

Published: June 21, 2016

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Journal: Nature genetics

Published: May 30, 2016

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

Journal: Cancer discovery

Published: October 12, 2015

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.

Journal: BMC cancer

Published: June 02, 2015

Common germline polymorphisms associated with breast cancer-specific survival.

Common germline polymorphisms associated with breast cancer-specific survival.

Journal: Breast cancer research : BCR

Published: November 07, 2014

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.

Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy.

Journal: Breast cancer research : BCR

Published: September 02, 2014

Prediction of breast cancer risk based on profiling with common genetic variants.

Prediction of breast cancer risk based on profiling with common genetic variants.

Journal: Journal of the National Cancer Institute

Published: March 28, 2014

Neoadjuvant chemotherapy for breast cancer with weekly nab-paclitaxel followed by epirubicin and cyclophosphamide--results of a case series.

Neoadjuvant chemotherapy for breast cancer with weekly nab-paclitaxel followed by epirubicin and cyclophosphamide--results of a case series.

Journal: In vivo (Athens, Greece)

Published: March 18, 2014

Showing 1-12 of 16

Last Updated: 09/26/2026